课题基金 / 基金详情

项目摘要

项目成果

Qingsheng Li的其他基金

相似基金

相关文献

中文摘要
翻译
尽管肛交是HIV-1的一种常见传播方式,尤其是男男性行为者,但仍存在许多基本和机制问题。这项研究的长期目标是了解HIV-1直肠传播的早期事件,并获得新的见解,这将有可能导致新的干预策略,包括针对直肠使用优化的疫苗和局部杀微生物剂。在高度相关的siv -恒河猴模型中研究HIV-1阴道传播已经揭示了传播的重要关键事件,如靶细胞可用性,先天免疫反应和入口炎症,所有这些因素都在传播中起关键作用。由于阴道和宫颈的解剖/组织学特征和生理功能与直肠不同,我们假设HIV-1直肠传播的潜在机制和时间将与阴道-宫颈传播的潜在机制和时间显著不同。利用创新的方法和从阴道传播研究中建立的概念框架,我们将通过调查三个具体目标来验证这一假设:1)确定病毒感染细胞在入口、引流和远端淋巴组织中的时间、位置、空间分布和细胞类型;2)确定直肠内SIV接种后不久病毒与易感靶细胞(CD4+ T细胞、巨噬细胞和树突状细胞)之间的关系,以及病毒感染细胞与直肠粘膜先天免疫反应之间的关系,从而确定靶细胞可用性的变化是否在感染的局部扩张和全身传播中起关键作用;3)确定病毒特异性CD8+ T效应细胞(E)和病毒感染靶细胞(T)在入口和其他组织室中的空间关系和比例,以控制病毒复制的程度;这项研究具有重要意义,因为它有望揭示直肠传播的重要机制,并可能为设计抗hiv -1疫苗和局部杀微生物剂提供指导。
英文摘要
Although anal intercourse is a common mode of HIV-1 transmission, particularly for men who have sex with men, many fundamental and mechanistic questions remain. The long-term objective of this study is to understand the early events in HIV-1 rectal transmission and to gain new insights, which will potentially lead to new intervention strategies, including vaccines and topical microbicides optimized for rectal use. Studying HIV-1 vaginal transmission in the highly relevant SIV-rhesus macaque model has revealed important events critical for transmission, such as target cell availability, innate immune response, and inflammation at the portal of entry, all factors which play a key role in transmission. Because the anatomical/histological features and the physiological functions of vagina and cervix differ from the rectum, we hypothesize that the underlying mechanisms and timing of HIV-1 rectal transmission will significantly differ from those of vaginal-cervical transmission. Utilizing innovative approaches and an established conceptual framework from studies of vaginal transmission, we will test this hypothesis by investigating three specific aims: 1) determine the timing, location, spatial distribution and cell types of virus-infected cells at the portal of entry and in draining and distal lymphatic tissues; 2) determine relationships between virus and susceptible target cells (CD4+ T cells, macrophages, and dendritic cells) and between virus-infected cells and the mucosal innate immune response in the rectum shortly after intra-rectal SIV inoculation, thereby determining whether changes in target-cell availability play a critical role in local expansion and systemic spread of infection; and 3) determine the spatial relationships and ratio of virus-specific CD8+ T effector cells (E) and virus-infected-target cells (T) at the portal of entry and in other tissue compartments to extent of control of virus replication, using a novel procedure combining in-situ tetramers and in-situ hybridization The proposed research is significant as it is expected to reveal important mechanisms underlying rectal transmission and potentially provide guidance for designing anti-HIV-1 vaccines and topical microbicides.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41426-018-0062-9
发表时间: 2018-04-04
期刊: Emerging microbes & infections
影响因子: 13.2
作者: [Yuan Z, Kang G, Daharsh L, Fan W, Li Q]
通讯作者: Li Q
Characterization of founder viruses in very early SIV rectal transmission.
在非常早期的SIV直肠传播中的创始人病毒的表征。
DOI: 10.1016/j.virol.2016.12.018
发表时间: 2017-02
期刊: Virology
影响因子: 3.7
作者: [Yuan Z, Ma F, Demers AJ, Wang D, Xu J, Lewis MG, Li Q]
通讯作者: Li Q
DOI: 10.4049/jimmunol.1502137
发表时间: 2016-02-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Vargas-Inchaustegui DA, Demers A, Shaw JM, Kang G, Ball D, Tuero I, Musich T, Mohanram V, Demberg T, Karpova TS, Li Q, Robert-Guroff M]
通讯作者: Robert-Guroff M
Mechanisms of resistance to immune therapy in NSCLC
  • 批准号:
    10093111
  • 项目类别:
  • 资助金额:
    $27.12万
  • 财政年份:
    2020
  • 负责人:
    Qingsheng Li
  • 依托单位:
Mechanisms of resistance to immune therapy in NSCLC
  • 批准号:
    10577776
  • 项目类别:
  • 资助金额:
    $25.11万
  • 财政年份:
    2020
  • 负责人:
    Qingsheng Li
  • 依托单位:
Mechanisms of resistance to immune therapy in NSCLC
  • 批准号:
    10333209
  • 项目类别:
  • 资助金额:
    $26.99万
  • 财政年份:
    2020
  • 负责人:
    Qingsheng Li
  • 依托单位:
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
  • 批准号:
    10515649
  • 项目类别:
  • 资助金额:
    $77.84万
  • 财政年份:
    2018
  • 负责人:
    Qingsheng Li
  • 依托单位:
海外基金